196 related articles for article (PubMed ID: 32839667)
1. Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations.
Goldstein E; Yeghiazaryan K; Ahmad A; Giordano FA; Fröhlich H; Golubnitschaja O
EPMA J; 2020 Sep; 11(3):505-515. PubMed ID: 32839667
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy and multiparametric analysis in management of liver malignancies: new concepts of the patient stratification and prognostic approach.
Golubnitschaja O; Polivka J; Yeghiazaryan K; Berliner L
EPMA J; 2018 Sep; 9(3):271-285. PubMed ID: 30174763
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach.
Golubnitschaja O; Potuznik P; Polivka J; Pesta M; Kaverina O; Pieper CC; Kropp M; Thumann G; Erb C; Karabatsiakis A; Stetkarova I; Polivka J; Costigliola V
EPMA J; 2022 Dec; 13(4):535-545. PubMed ID: 36415625
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions.
Kucera R; Pecen L; Topolcan O; Dahal AR; Costigliola V; Giordano FA; Golubnitschaja O
EPMA J; 2020 Sep; 11(3):399-418. PubMed ID: 32843909
[TBL] [Abstract][Full Text] [Related]
6. Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours.
Golubnitschaja O; Yeghiazaryan K; Stricker H; Trog D; Schild HH; Berliner L
BMC Cancer; 2016 Jun; 16():357. PubMed ID: 27277077
[TBL] [Abstract][Full Text] [Related]
7. The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
Golubnitschaja O; Polivka J; Potuznik P; Pesta M; Stetkarova I; Mazurakova A; Lackova L; Kubatka P; Kropp M; Thumann G; Erb C; Fröhlich H; Wang W; Baban B; Kapalla M; Shapira N; Richter K; Karabatsiakis A; Smokovski I; Schmeel LC; Gkika E; Paul F; Parini P; Polivka J
EPMA J; 2024 Mar; 15(1):1-23. PubMed ID: 38463624
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine.
Zhan X; Li J; Guo Y; Golubnitschaja O
EPMA J; 2021 Dec; 12(4):449-475. PubMed ID: 34876936
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
10. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine.
Wang W; Yan Y; Guo Z; Hou H; Garcia M; Tan X; Anto EO; Mahara G; Zheng Y; Li B; Kang T; Zhong Z; Wang Y; Guo X; Golubnitschaja O;
EPMA J; 2021 Dec; 12(4):403-433. PubMed ID: 34539937
[TBL] [Abstract][Full Text] [Related]
11. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context.
Skladany L; Koller T; Adamcova Selcanova S; Vnencakova J; Jancekova D; Durajova V; Laffers L; Svac J; Janickova K; Palkovič M; Kohout P; Golubnitschaja O
EPMA J; 2021 Mar; 12(1):1-14. PubMed ID: 33680218
[TBL] [Abstract][Full Text] [Related]
12. Making a complex dental care tailored to the person: population health in focus of predictive, preventive and personalised (3P) medical approach.
Tachalov VV; Orekhova LY; Kudryavtseva TV; Loboda ES; Pachkoriia MG; Berezkina IV; Golubnitschaja O
EPMA J; 2021 Jun; 12(2):129-140. PubMed ID: 33897916
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021.
Golubnitschaja O; Liskova A; Koklesova L; Samec M; Biringer K; Büsselberg D; Podbielska H; Kunin AA; Evsevyeva ME; Shapira N; Paul F; Erb C; Dietrich DE; Felbel D; Karabatsiakis A; Bubnov R; Polivka J; Polivka J; Birkenbihl C; Fröhlich H; Hofmann-Apitius M; Kubatka P
EPMA J; 2021 Sep; 12(3):243-264. PubMed ID: 34422142
[TBL] [Abstract][Full Text] [Related]
15. Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.
Mazurakova A; Samec M; Koklesova L; Biringer K; Kudela E; Al-Ishaq RK; Pec M; Giordano FA; Büsselberg D; Kubatka P; Golubnitschaja O
EPMA J; 2022 Sep; 13(3):461-486. PubMed ID: 35821883
[TBL] [Abstract][Full Text] [Related]
16. Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma.
Ricke J; Schinner R; Seidensticker M; Gasbarrini A; van Delden OM; Amthauer H; Peynircioglu B; Bargellini I; Iezzi R; De Toni EN; Malfertheiner P; Pech M; Sangro B
J Hepatol; 2021 Dec; 75(6):1387-1396. PubMed ID: 34454995
[TBL] [Abstract][Full Text] [Related]
17. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
[TBL] [Abstract][Full Text] [Related]
18. Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare.
Zubor P; Dankova Z; Kolkova Z; Holubekova V; Brany D; Mersakova S; Samec M; Liskova A; Koklesova L; Kubatka P; Bujnak J; Kajo K; Mlyncek M; Giordano FA; Golubnitschaja O
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32443784
[TBL] [Abstract][Full Text] [Related]
19. Bidirectional deep neural networks to integrate RNA and DNA data for predicting outcome for patients with hepatocellular carcinoma.
Huang G; Wang C; Fu X
Future Oncol; 2021 Nov; 17(33):4481-4495. PubMed ID: 34374301
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
